Accepted Preprint first posted online on 29 December 2008
Journal of Molecular Endocrinology 2009;42:269.
Journal of Molecular Endocrinology (2008) In press DOI: 10.1677/JME-08-0142
© 2008 Society for Endocrinology
The skeletal phenotypes of TRalpha and TRbeta mutant mice.
Duncan Bassett and
Graham Williams
D Bassett, Metabolic Medicine, Imperial College London, London, W12 0NN, United Kingdom
G Williams, Molecular Endocrinology Group, Imperial College London, London, United Kingdom
Correspondence: Duncan Bassett, Email: d.bassett{at}imperial.ac.uk
Abstract
Analysis of mice harbouring deletions or mutations of thyroid hormone receptor
(TR
) and β (TRβ) have clarified the complex relationship between central and peripheral thyroid status and emphasised the essential but contrasting roles of thyroid hormone (T3) in skeletal development and adult bone. These studies indicate that TR
1 is the predominant TR expressed in bone and that T3 exerts anabolic actions during growth but catabolic actions in the adult skeleton. Examination of key skeletal regulatory pathways in TR mutant mice has identified growth hormone, insulin like growth factor 1 and fibroblast growth factor signalling and the Indian hedgehog/parathyroid hormone-related peptide feed back loop as major targets of T3 action in chondrocytes and osteoblasts. Nevertheless, although increased osteoclastic resorption is a major feature of thyrotoxic bone loss and altered osteoclast activity is central to the skeletal phenotype of TR mutant mice, it remains unclear whether T3 has direct actions in osteoclasts. Detailed future analysis of the molecular mechanisms of T3 action in bone will enhance our understanding of this emerging field and has the potential to identify novel strategies for prevention and treatment of osteoporosis.
Copyright © 2008 by the Society for Endocrinology.